Search results
Found 29668 matches for
Matthew has been awarded a Diabetes Research Wellness Foundation Non-Clinical Research Fellowship.
A Summer of Community & Celebration
19 September 2025
From the Lab to Milan
19 September 2025
Body-in-a-chip approach reveals how immune cells respond to heart injury
11 September 2025
Oxford scientists build a connected, ‘multi-organoid’ platform that recreates immune recruitment to the heart, opening new avenues to probe disease and test therapies.
Christos Kotanidis wins ESC Young Investigator Award 2025 in Preventive Cardiology
8 September 2025
Congratulations to Dr Christos Kotanidis, NIHR-funded Academic Clinical Lecturer in Cardiology, who has been awarded the 2025 ESC Young Investigator Award in Preventive Cardiology at the European Society of Cardiology Congress in Madrid.
Weight loss alone doesn’t ease atrial fibrillation symptoms in older adults, study finds
29 August 2025
A clinical trial led by researchers in the University of Oxford’s Radcliffe Department of Medicine and Oxford Population Health, has found that while a structured weight-loss programme helped older adults with atrial fibrillation (AF) shed weight safely and sustainably, it did not improve their heart rhythm s…
DPhil sponsorship agreement with medical university and hospital /medical centre in Taiwan
29 August 2025
On 28 August, RDM signed a Memorandum of Understanding with the National Defense Medical University and Tri-Service General Hospital in Taiwan which will provide funding for their students who have successfully enrolled on the DPhil in Medical Sciences.
‘Targeted Therapies’ at Big Bang Fair 2025
20 August 2025
Earlier this year, a group of researchers from the MRC Weatherall Institute of Molecular Medicine attended the Big Bang Fair in Birmingham, showcasing medical research through a series of hands-on activities.
Scientists reveal how new diabetes and obesity drugs work
19 August 2025
A team led by scientists at the University of Oxford and the Leibniz-Forschungsinstitut für Molekulare Pharmakologie in Berlin has used fluorescent versions of next-generation diabetes and obesity drugs to reveal, for the first time, exactly which cells they target in the pancreas and brain.
Precision Cellular Therapeutics Annual Meeting 2025
15 August 2025
Platelets Shown to Store DNA in Study that could Transform Cancer Screening
15 August 2025
Study led by Psaila Group uncovers previously unknown function of platelets as DNA ‘vacuum cleaners’ in the blood, with profound implications for cancer diagnosis and prenatal screening.
RDM DM student awarded prestigious Ramsay Scholarship
7 August 2025
RDM Doctor of Medicine (DM) student Nicholas Clarke is one of 28 exceptional young people awarded the 2025 Ramsay Postgraduate Scholarship.
Wellcome Discovery Award for Claus Nerlov
31 July 2025
Claus Nerlov, Professor of Stem Cell Biology, has been awarded funding from Wellcome to map the gene regulatory networks in blood cell production and seek new therapeutic targets.
New study links cancer stage to strength of antitumoral immune response in HR+ breast cancer
29 July 2025
The latest study from researchers in the MRC Translational Immune Discovery Unit in the MRC Weatherall Institute of Molecular Medicine has been published in Cell Reports Medicine.
Changing perceptions about patient outcomes
25 July 2025
Immune cells show promise in treating hypertrophic cardiomyopathy
21 July 2025
A new study from scientists at the Radcliffe Department of Medicine and Harvard Medical School, and funded by the British Heart Foundation, has uncovered a potential new treatment for hypertrophic cardiomyopathy (HCM).
Spotlight on Mara Cenerenti
18 July 2025
£1.3m MRC Partnership Grant to expand the use of innovative Hyperpolarised Magnetic Resonance Imaging
15 July 2025
The technology has the potential to revolutionise the detection and monitoring of disease
Making it Personal – Engaging the public through theatre
14 July 2025
Innovative public engagement project explores the intersection of cutting-edge science and the raw honesty of the stage.
Thelior Bio: rethinking gut health from the inside out
10 July 2025
A new spinout company, formed from research conducted at the MRC Translational Immune Discovery Unit, aims to develop a new class of therapies for patients with inflammatory bowel disease.
We’re getting (more) engaged!
4 July 2025